Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer	Breast Neoplasm Female	Active, not recruiting	Phase 3	2026-05-20		NCT03425838

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Borstkanker Onderzoek Groep	13

72 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Admiraal de Ruyter	Goes	Netherlands	1
Albert Schweitzer Ziekenhuis	Dordrecht	Netherlands	17
Alexander Monro ziekenhuis	Bilthoven	Netherlands	3
Alrijne Ziekenhuis	Leiden	Netherlands	3
AMC	Amsterdam	Netherlands	2
Amphia	Breda	Netherlands	12
Antonius Ziekenhuis	Sneek	Netherlands	6
Bernhoven	Uden	Netherlands	5
BovenIJ ziekenhuis	Amsterdam	Netherlands	2
Bravis ziekenhuis	Roosendaal	Netherlands	16
Canisius-Wilhelmina Ziekenhuis	Nijmegen	Netherlands	3
Catharina Ziekenhuis	Eindhoven	Netherlands	43
Deventer Ziekenhuis	Deventer	Netherlands	21
Diakonessenhuis	Utrecht	Netherlands	17
Dijklander Ziekenhuis	Hoorn	Netherlands	12
Elisabeth Tweesteden	Tilburg	Netherlands	1
Elkerliek ziekenhuis	Helmond	Netherlands	7
Erasmus MC	Rotterdam	Netherlands	3
Flevoziekenhuis	Almere Stad	Netherlands	17
Franciscus Gasthuis & Vlietland	Rotterdam	Netherlands	7
Gelderse Vallei	Ede	Netherlands	2
Gelre ziekenhuizen	Apeldoorn	Netherlands	9
Groene Hart Ziekenhuis	Gouda	Netherlands	14
Haaglanden Medisch Centrum	The Hague	Netherlands	18
HagaZiekenhuis	The Hague	Netherlands	18

Clinical trials